Last Updated: 05/07/15
Last price: 10.04 Total volume: 158,087
ANFI Stock Chart - 1 Month
ANFI Stock Chart - 3 Month
ANFI Stock Chart - 6 Month
ANFI Stock Chart - 1 Year
ANFI Stock Chart - 2 Year
Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...
Continue Reading
When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...
Continue Reading
In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...
Continue Reading
America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...
Continue Reading
Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...
Continue Reading
AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...
Continue Reading
Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...
Continue Reading
AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...
Continue Reading
Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...
Continue Reading
Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...
Continue Reading
Ascendis Pharma Reports Mixed Q2 Results Ascendis Pharma A/S (NASDAQ: ASND) has unveiled its financial results for the second quarter of 2024, revealing a mix of achievements and hurdles. A significant highlight of this quarter was the U.S. approval of YORVIPATH for the treatment of adult hypoparathyroidism. This marks a major milestone as it represents the company's...
Continue Reading
New Zealand’s Economic Growth Overview New Zealand's latest growth figures present a significant turning point for a nation that has been adjusting to the impacts of substantial monetary easing. The economy showed a quarterly expansion of 1.1%, bouncing back after a contraction of 1.0% previously. This growth not only exceeded expectations, which were around 0.9%, but...
Continue Reading
Exploring Eli Lilly's Impact on the Pharmaceuticals Sector In the dynamic and competitive world of pharmaceuticals, understanding the role of companies like Eli Lilly & Co. (NYSE: LLY) is crucial for investors and stakeholders alike. This article offers a detailed comparative analysis of Eli Lilly's performance against its main competitors, focusing on key financial...
Continue Reading
Veriff Expands Its Board with Industry Expertise Veriff, an innovative identity verification company known for its AI-native technology, recently appointed Ott Kaukver to its Board of Directors. This significant move illustrates the company’s determination to enhance trust in online identities globally. Kaukver, recognized for his role as the former CTO of Twilio and...
Continue Reading
University of Phoenix Launches Center for AI Resources University of Phoenix has taken a significant step towards empowering its students and faculty by launching the Center for AI Resources. This initiative is designed to equip learners with essential knowledge for navigating the increasingly complex landscape of generative AI (GenAI). The Center serves as a...
Continue Reading